BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25681263)

  • 21. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008.
    Owusu-Edusei K; Chesson HW; Gift TL; Tao G; Mahajan R; Ocfemia MC; Kent CK
    Sex Transm Dis; 2013 Mar; 40(3):197-201. PubMed ID: 23403600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic and humanistic burden of external genital warts.
    Raymakers AJ; Sadatsafavi M; Marra F; Marra CA
    Pharmacoeconomics; 2012 Jan; 30(1):1-16. PubMed ID: 22201520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evidence-based review of medical and surgical treatments of genital warts.
    Scheinfeld N; Lehman DS
    Dermatol Online J; 2006 Mar; 12(3):5. PubMed ID: 16638419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts.
    Langley PC; Tyring SK; Smith MH
    Am J Manag Care; 1999 Jan; 5(1):69-77. PubMed ID: 10345969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB; Legler A; Hanchate A
    Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
    Park IU; Introcaso C; Dunne EF
    Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of the impact of genital warts on health-related quality of life.
    Woodhall S; Ramsey T; Cai C; Crouch S; Jit M; Birks Y; Edmunds WJ; Newton R; Lacey CJ
    Sex Transm Infect; 2008 Jun; 84(3):161-6. PubMed ID: 18339658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
    McCormack PL; Joura EA
    BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations.
    Camenga DR; Dunne EF; Desai MM; Gee J; Markowitz LE; Desiliva A; Klein NP
    Sex Transm Dis; 2013 Jul; 40(7):534-8. PubMed ID: 23965766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new surveillance gynecological network to assess the incidence and prevalence of genital warts in the Italian female population: lessons learned.
    Suligoi B; Salfa MC; Mariani L; Corsini D; Timelli L; Fattorini G; Vittori G
    Minerva Ginecol; 2013 Oct; 65(5):577-85. PubMed ID: 24096294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
    Oliphant J; Perkins N
    N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Quality of life of patients with condyloma].
    Mortensen GL; Larsen HK
    Ugeskr Laeger; 2008 Nov; 170(47):3858-62. PubMed ID: 19014739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genital warts in a transsexual.
    Wasef W; Sugunendran H; Alawattegama A
    Int J STD AIDS; 2005 May; 16(5):388-9. PubMed ID: 15949073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
    Annemans L; Rémy V; Lamure E; Spaepen E; Lamotte M; Muchada JP; Largeron N
    J Med Econ; 2008; 11(1):135-50. PubMed ID: 19450115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing the health burden of HPV infection through vaccination.
    Soper D
    Infect Dis Obstet Gynecol; 2006; 2006 Suppl():83084. PubMed ID: 16967913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burden of Disease of Human Papillomavirus (HPV): Hospitalizations in the Marche and Veneto Regions. An observational study.
    Mennini FS; Fabiano G; Marcellusi A; Sciattella P; Saia M; Cocchio S; Baldo V
    Clin Drug Investig; 2018 Feb; 38(2):173-180. PubMed ID: 29081028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999--2004.
    Dinh TH; Sternberg M; Dunne EF; Markowitz LE
    Sex Transm Dis; 2008 Apr; 35(4):357-60. PubMed ID: 18360316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of male human papillomavirus vaccination in preventing cervical cancer and genital warts in a low-resource setting.
    Sharma M; Sy S; Kim JJ
    BJOG; 2016 May; 123(6):917-26. PubMed ID: 26176301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme.
    Chow EP; Read TR; Wigan R; Donovan B; Chen MY; Bradshaw CS; Fairley CK
    Sex Transm Infect; 2015 May; 91(3):214-9. PubMed ID: 25305210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.
    Kjaer SK; Tran TN; Sparen P; Tryggvadottir L; Munk C; Dasbach E; Liaw KL; Nygård J; Nygård M
    J Infect Dis; 2007 Nov; 196(10):1447-54. PubMed ID: 18008222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.